SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Global X Funds - Global X Silver Miners ETF

Global X Silver Miners ETF (SIL) is currently trending as investors capitalize on a pronounced structural supply-demand deficit in the silver market and an impulsive breakout in price, with community discourse heavily focused on long-term industrial demand and the potential for a massive 'catch-up' rally in miners relative to the metal's spot price.

Visa, Inc. engages in the provision of digital payment services. It also facilitates global commerce through the transfer of value and information among a global network of consumers, merchants, financial institutions, businesses, strategic partners, and government entities. It offers debit cards, credit cards, prepaid products, commercial payment solutions, and global automated teller machines. The company was founded by Dee Hock in 1958 and is headquartered in San Francisco, CA.

Visa Inc - Ordinary Shares - Class A

Visa Inc

Visa shares are facing significant volatility following recent political rhetoric regarding a proposed cap on credit card interest rates, sparking investor concern despite the firm's role as a payment network rather than a direct lender. The community is actively debating whether this selloff represents an irrational overreaction to political posturing or a fundamental threat to the long-term payment ecosystem, with many traders looking for reversal opportunities near key support levels.

OneMain Holdings, Inc. is a consumer finance company, which engages in the origination, underwriting, and servicing of personal loans, primarily to non-prime customers. It operates through the Consumer and Insurance segment. The Consumer and Insurance segment offers services to secured and unsecured personal loans, voluntary credit, and non-credit insurance, and related products through its combined branch network, digital platform, and centralized operations. The company was founded on August 5, 2013 and is headquartered in Evansville, IN.

OneMain Holdings Inc

OneMain Holdings is experiencing significant investor attention driven by its high dividend yield and status as a value play in the consumer finance sector, despite ongoing concerns regarding credit normalization and legal challenges from state regulators. While some investors see the stock as a compelling long-term hold due to its consistent shareholder returns and buyback programs, others remain cautious about potential risks in subprime lending and the broader macroeconomic environment.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is currently a focal point of debate as investors weigh significant structural changes, including a newly appointed Board of Directors and a shift toward expanded U.S. operations, against persistent downward price pressure. While some in the community see these strategic pivots and ongoing network activity as long-term positioning for institutional adoption, others are actively expressing frustration over the project's recent performance and the broader volatility across the altcoin sector.

AGNC Investment Corp. engages in the operation of a real estate investment trust. The firm invests in residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by the United States government-sponsored enterprise or by the United States government agency. It also invests in other types of mortgage and mortgage-related securities, such as credit risk transfer securities and non-Agency residential and commercial mortgage-backed securities, where repayment of principal and interest is not guaranteed by the United States government-sponsored enterprise or by the United States Government agency, and other assets related to the housing, mortgage, or real estate markets. The company was founded on January 7, 2008 and is headquartered in Bethesda, MD.

AGNC Investment Corp

AGNC Investment Corp is trending as investors weigh its attractive double-digit monthly dividend yield against a backdrop of volatile mortgage-backed securities markets and uncertainty surrounding Federal Reserve rate path adjustments. Community sentiment remains polarized, with many dividend-focused participants actively accumulating shares on pullbacks to capture high yields, while others raise concerns over the company's valuation relative to its book value and the potential impact of macro headwinds.

Blacksky Technology, Inc. is a space-based intelligence company, which engages in the business of delivering real-time imagery, analytics, and high-frequency monitoring of most critical and strategic locations, economic assets, and events. The firm is also involved in providing geospatial intelligence, imagery and related data analytic products and services, and mission systems that include the development, integration, and operation of satellite and ground systems to government and commercial customers. The company was founded in 2014 and is headquartered in Herndon, VA.

BlackSky Technology Inc - Ordinary Shares - Class A

BlackSky Technology is gaining significant attention as investors monitor the company's progress on Gen-3 satellite launches and its ability to secure critical multi-million dollar defense contracts. The community is actively debating the stock's valuation relative to its growth potential and sector peers, with many focusing on whether recent technical setups and institutional interest will trigger a shift in momentum.

Oscar Health, Inc. is a healthcare insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Health is experiencing heightened volatility and intense community debate ahead of its earnings release, with bulls highlighting its rapid membership growth and AI-driven efficiency as key long-term catalysts. Meanwhile, bears are pointing to the company's exposure to regulatory risk and concerns over whether recent revenue expansion can translate into sustainable profitability.

The Charles Schwab Corp. is a savings and loan holding company, which engages in the provision of wealth management, securities brokerage, banking, asset management, custody, and financial advisory services. It operates through the Investor Services and Advisor Services segments. The Investor Services segment includes retail brokerage, investment advisory, and banking and trust services to individual investors, retirement plan and business services, as well as other corporate brokerage services, to businesses and employees. The Advisor Services segment provides custodial, trading, banking and trust, and support services to independent registered investment advisors, independent retirement advisors, and recordkeepers. The company was founded by Charles Robert Schwab in 1986 and is headquartered in Westlake, TX.

Charles Schwab Corp.

Charles Schwab is trending as investors digest a series of mixed monthly asset growth reports and navigate broader financial sector volatility linked to changing interest rate expectations. The community is actively discussing the platform's trading limitations and service reliability compared to emerging competitors, while analysts continue to weigh the firm's strategic push into private markets against fears of fee compression from AI-driven financial tools.

BlockDAG is a hybrid concept that combines features of both traditional blockchains and DAGs. It retains the benefits of DAGs, such as high scalability and faster transaction processing, while integrating the security and trust of blockchain consensus mechanisms. BlockDAG emerges as a groundbreaking solution, meticulously merging the strengths of both blockchain and DAG architectures. It leverages the robust security and decentralization of blockchains while incorporating the efficient, scalable transaction processing of DAGs. This strategic integration allows blockDAG to handle a significantly higher volume of transactions at faster speeds compared to traditional blockchains. By overcoming the inherent limitations of both technologies, blockDAG paves the way for a future where distributed ledgers can seamlessly scale to meet the ever-growing demands of the cryptocurrency and broader digital landscape.

BlockDAG

BlockDAG is currently trending as users grapple with ongoing difficulties regarding token claims, wallet connectivity, and the transition from presale to mainnet. The community is sharply divided, with many expressing frustration over alleged technical failures and perceived lack of transparency, while others remain optimistic about the project's long-term utility and future exchange potential.

PolySwarm

PolySwarm ($NCT) is trending as the community debates whether the token is primed for a significant breakout, driven by its cybersecurity utility and expectations that capital will rotate from major assets into real-world utility projects. While many users express frustration over stagnant price action and previous false starts, sentiment remains focused on long-term accumulation, with many watching for increased volume as a catalyst for a potential shift in momentum.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Century Therapeutics (NASDAQ:IPSC) SVP Sells $17,959.65 in Stock

Century Therapeutics, Inc. (NASDAQ:IPSC - Get Free Report) SVP Douglas Carr sold 7,043 shares of the company's stock in a transaction on Thursday, March 12th. The stock was sold at an average price...

Century Therapeutics (NASDAQ:IPSC) Insider Sells $25,693.80 in Stock

Century Therapeutics, Inc. (NASDAQ:IPSC - Get Free Report) insider Gregory Russotti sold 10,076 shares of the business's stock in a transaction that occurred on Thursday, March 12th. The stock was...

Century Therapeutics, Inc. (NASDAQ:IPSC) Sees Large Growth in Short Interest

Century Therapeutics, Inc. (NASDAQ:IPSC - Get Free Report) was the target of a large increase in short interest during the month of February. As of February 27th, there was short interest totaling...

Century Therapeutics (NASDAQ:IPSC) Announces Quarterly Earnings Results, Beats Estimates By $0.04 EPS

Century Therapeutics (NASDAQ:IPSC - Get Free Report) issued its quarterly earnings data on Thursday. The company reported ($0.25) earnings per share (EPS) for the quarter, topping the consensus...

Century Therapeutics (IPSC) to Release Quarterly Earnings on Wednesday

Century Therapeutics (NASDAQ:IPSC) will be releasing its Q4 2025 earnings before the market opens on Wednesday, March 18. (View Earnings Report at...

Century Therapeutics (NASDAQ:IPSC) Raised to "Hold" at Wall Street Zen

Wall Street Zen upgraded Century Therapeutics from a "sell" rating to a "hold" rating in a research note on Saturday...

Century Therapeutics, Inc. (NASDAQ:IPSC) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Century Therapeutics, Inc. (NASDAQ:IPSC - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the eight analysts that are presently covering the firm, Marketbeat reports. One...

Century Therapeutics, Inc. (NASDAQ:IPSC) Short Interest Up 39.8% in February

Century Therapeutics, Inc. (NASDAQ:IPSC - Get Free Report) saw a significant increase in short interest during the month of February. As of February 13th, there was short interest totaling 4,739,771...

Century Therapeutics (NASDAQ:IPSC) Now Covered by Analysts at TD Cowen

TD Cowen assumed coverage on shares of Century Therapeutics in a report on Wednesday. They set a "buy" rating for the company...

Short Interest in Century Therapeutics, Inc. (NASDAQ:IPSC) Expands By 320.2%

Century Therapeutics, Inc. (NASDAQ:IPSC - Get Free Report) was the recipient of a significant increase in short interest in the month of January. As of January 30th, there was short interest totaling...

$IPSC Q4 &#39;25 Earnings Results &amp; Recap

Century Therapeutics believes its cash, cash equivalents, and investments of $117.1M as of December 31, 2025, plus $126.7M from a 2026 private placement, will fund operations into Q1 2029.

Stocktwits

Century Therapeutics Inc

 Q4 '25 Earnings Results & Recap

Century Therapeutics believes its cash, cash equivalents, and investments of $117.1M as of December 31, 2025, plus $126.7M from a 2026 private placement, will fund operations into Q1 2029.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

Century Therapeutics, Inc. engages in the development of off-the-shelf cell therapies to advance the course of cancer care. It focuses on harnessing the power of adult stem cells to develop curative allogeneic cell therapies for cancer. The company was founded by Marcela Maus and Hiromitsu Nakauchi in 2018 and is headquartered in Philadelphia, PA.

Current Price	$2.42
Prev Close	$2.49
Open	$2.50
Dividend Yield	0.00%
50-Day Moving Average	$2.18
Beta	1.55
Avg. Volume	957,485.67
PE Ratio	-22.98

52-Week High	$3.04
52-Week Low	$0.3418
Market Capitalization	$434.93M
EPS (Annual)	-$0.1107
Price to Book	1.33
Revenue Per Employee	$1.4M

IPSC
Century Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest IPSC News

IPSCCentury Therapeutics Inc